Actively Recruiting
Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Led by National Cancer Institute, Egypt · Updated on 2024-05-14
172
Participants Needed
1
Research Sites
119 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
CONDITIONS
Official Title
Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for modified radical mastectomy
- Age between 18 and 65 years
- ASA physical status I or II
You will not qualify if you...
- Patient refusal
- Coagulation defects
- Abnormal kidney or liver functions
- Local infection at site of injection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Walaa Y Elsabeeny
Cairo, Egypt, 11796
Actively Recruiting
Research Team
W
Walaa Y Elsabeeny, MD
CONTACT
N
Nahla N Shehab, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here